Samaritan Pharmaceutical (fka SPHC)

[stkstupid]

JAKE & Baiter,

You two have this board to yourselves so far. I've been into LIV for 2 yrs. I have nice holdings. Just about dead even $ wise. I was worried at the .32 number but the rebound was a relief.

I have followed several Biotechs for the past couple years. They had their day back in the 90's when blind speculation inflated and distorted everything. Today, Bio's have settled into a niche where they tend to play along like LIV then go to the $2.00 to $3.00 area when they go into Phase III testing. It takes a while to break out even with FDA approval but once they get sales going, it is an upward climb. TTP shot up to $60.00 at one time on speeculation then crashed on a PhIII abort. It's in a 2.00 to 3.00 range today with a major pipeline. Very close to a break out in the $5 to $8 range. Some say $20.00 but we all dream. A new IPO, VNDA has mrktng rts to TTP's first drug, Iloperidone, an opiate supressor. UGNE has their approval for an inhalant Ostioporosis drug and they are just starting to move above the $5.00 range as sales revenues come in. Been with these babies for a long time but they never seemed as risky as LIV.

The big thing with TTP and UGNE is their backing from big Pharma. That's what we need with LIV, a big brother that believes in the pipe line and wants a piece of the action. A Georgetown alumnus in the right place.

GH